Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Trends in Vascular Complications After Diagnostic.
Advertisements

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. Patterns and Predictors of Stress Testing Modality After.
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peripheral Artery Disease: Evolving Role of Exercise,
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Thrombosis of Second-Generation Drug-Eluting Stents.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Relationship Between Pre-Eclampsia and Peripartum.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Elevated Plasma Levels of Neuropeptide Proenkephalin.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The impact of plasma levels of C-reactive protein,
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Genetic Inhibition of CETP, Ischemic Vascular Disease.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Introducing High-Sensitivity Cardiac.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Practical Management of Anticoagulation in Patients.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Elevated Plasma Fibrinogen Rather Than Residual.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Trends, Predictors, and Outcomes of Cerebrovascular.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Heavy Metals, Cardiovascular Disease, and the Unexpected.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Clinical Results Following Stenting of.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Heparin-Bonded Covered Stents Versus Bare-Metal Stents.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reduced-Function CYP2C19 Genotype and Risk of Adverse.
Supplementary Appendix Thrombotic Risk Scores % of Patients Risk Categories Low Risk (n=3491) Intermediate Risk (n=2806)
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiovascular Effect of Bans on Smoking in Public.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Non–ST-Segment Elevation Acute Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Benefit of Early Invasive Therapy in Acute Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Usual Blood Pressure and Risk of New-Onset Diabetes:
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Ethnic Differences in the Prognostic Value of Coronary.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: U.S. Hospital Use of Echocardiography: Insights.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Gastrointestinal Bleeding in Patients With Atrial.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Anticoagulation of Bioprosthetic Aortic Valves.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effectiveness of In-Laboratory High-Dose Clopidogrel.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.
Figure 1 Ischaemic endpoints
John A. Bittl et al. JACC 2016;68:
Overall (n=301) Acute/Subacute (n=149) Late (n=152) p Presentation
Presentation transcript:

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Prevalence and Overlap of Complex PCI Components Prevalence of complex PCI components in the overall population. PCI = percutaneous coronary intervention.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Effect of Procedural Complexity on Ischemic and Bleeding Outcomes Cumulative hazard curves for major adverse cardiac events (A), coronary thrombotic events (B), and major bleeding (C). Incidence rates are expressed as 100 patient-years of follow-up. CI = confidence interval; HR = hazard ratio; IRD = incidence rate difference; PCI = percutaneous coronary intervention.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Effect of High-Risk Procedural Subsets on Ischemic Outcomes Adjusted risk of major adverse cardiac events (A), coronary thrombotic events (B), definite or probable stent thrombosis (C), and myocardial infarction (D) across high-risk procedural subsets. *Not estimable because the number of events was too low. Incidence rates are expressed as 100 patient-years of follow-up. Abbreviations as in Figure 2.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Intention-to-Treat Analysis for Long- Versus Short-Term DAPT in Patients With or Without Complex PCI Cumulative hazard curves for long-term DAPT versus short-term DAPT for major adverse cardiac events (A), coronary thrombotic events (B), and major bleeding (C) in patients with or without complex PCI. Incidence rates are expressed as 100 patient-years of follow-up. DAPT = dual antiplatelet therapy; other abbreviations as in Figure 2.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Ischemic Benefit of Long-Term DAPT According to the Degree of PCI Complexity DAPT for ≥1 year significantly reduced the risk of major adverse cardiac events after complex PCI compared with 3 or 6 months of DAPT. Complex PCI was defined as the composite of 3 vessels treated, ≥3 stents implanted, ≥3 lesions treated, bifurcation with 2 stents implanted, total stent length >60 mm, or chronic total occlusion. The y-axis displays the adjusted hazard ratios for long-term DAPT on risk of major adverse cardiac events. The x-axis displays the number of high-risk procedural features. Incidence rate differences per 100 patient-years of follow-up per number of high-risk procedural features are displayed above the plot. Complex PCI is associated with increased risk of major adverse cardiac events with a magnitude comparable to that of traditional clinical risk factors (i.e., prior myocardial infarction or acute coronary syndrome presentation). The magnitude of the anti-ischemic effect of long-term DAPT trended to be greater for increase in PCI complexity. CI = confidence interval; DAPT = dual antiplatelet therapy; IRD = incidence rate differences; PCI = percutaneous coronary intervention.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI J Am Coll Cardiol. 2016;68(17): doi: /j.jacc Figure Legend: Per-Treatment Analysis for Long- Versus Short-Term DAPT in Patients With or Without Complex PCI Cumulative hazard curves for long-term versus short-term DAPT for major adverse cardiac events (A), coronary thrombotic events (B), and major bleeding (C) in patients with or without complex PCI. Incidence rates are expressed as 100 patient-years of follow-up. Abbreviations as in Figures 2 and 4.